SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects

NCT05476107 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: AMT-126
DRUG: Placebo
OTHER: Radioactive Tablet (Part 2 Only)

Sponsor

Applied Molecular Transport